Gain Therapeutics, Inc. (NASDAQ:GANX) Receives Average Rating of "Moderate Buy" from Analysts
Shares of Gain Therapeutics, Inc. (NASDAQ:GANX - Get Free Report) have received an average rating of "Moderate Buy" from the eight brokerages that are currently covering the company, Marketbeat...